MGMT promoter methylation in plasma of glioma patients receiving temozolomide

Author： Fiano Valentina   Trevisan Morena   Trevisan Elisa   Senetta Rebecca   Castiglione Anna   Sacerdote Carlotta   Gillio-Tos Anna   Marco Laura   Grasso Chiara   Magistrello Michela   Tondat Fabrizio   Rudà Roberta   Cassoni Paola   Soffietti Riccardo   Merletti Franco  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.117, Iss.2, 2014-04, pp. : 347-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

By                      

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 654-658

Spandidos Publications

Access to resources Recommend Favorite

MGMT promoter methylation and temozolomide response in choroid plexus carcinoma

By Misaki Kouichi  

Brain Tumor Pathology, Vol. 28, Iss. 3, 2011-07 ,pp. : 259-263

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation in serum and cerebrospinal fluid as a tumorspecific biomarker of glioma

By              

Biomedical Reports, Vol. 3, Iss. 4, 2015-01 ,pp. : 543-548

Science Publishers

Access to resources Recommend Favorite

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients

By Balañá Carmen  

Clinical and Translational Oncology, Vol. 13, Iss. 9, 2011-09 ,pp. : 677-685

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation in malignant gliomas

By Riemenschneider Markus  

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite